Phase 3VascularRecruiting
Golazo® GREAT — Peripheral Atherectomy
Peripheral Artery Disease
About this study
Pivotal evaluation of an advanced peripheral atherectomy system for treatment of calcified lower-extremity arterial disease.
Sponsor: Cardiovascular Systems Inc.
Key eligibility
- Adults 18+ with symptomatic PAD
- Rutherford Class 2–4
- Suitable target lesion on imaging
Eligibility above is a summary. Final qualification is determined by the study protocol and a screening visit with our team.
What participation involves
Most studies follow the same general flow: a phone pre-screen, an in-person screening visit, informed consent, baseline testing, the treatment phase, and follow-up visits. Study-related care is provided at no cost. You may withdraw at any time, for any reason.
Note
This page is a plain-language overview. For the official, definitive protocol summary, please refer to ClinicalTrials.gov or speak with our coordinator.